Literature DB >> 8082887

Lipopeptide-polyoxyethylene conjugates as mitogens and adjuvants.

B Kleine1, W Rapp, K H Wiesmüller, M Edinger, W Beck, J Metzger, R Ataulakhanov, G Jung, W G Bessler.   

Abstract

Two lipopeptide analogues of the Escherichia coli lipoprotein rendered water-soluble by polyoxyethylene were tested for mitogenicity in vitro in murine and human B lymphocytes and for adjuvant activity in vivo in mice. These highly amphiphilic lipopeptides retained the biological activity other lipopeptides usually exerted which supports the hypothesis of specific interactions of lipopeptides with membranes of reactive cells. The activation of human B lymphocytes by these lipopeptides was much less pronounced compared to that of murine cells. However, given in combination with anti-CD40 antibodies plus interleukin-4, human B lymphocytes could synergistically be stimulated to proliferate. As an adjuvant, the polyoxyethylene linked lipopeptides were almost as potent as Freund's adjuvants and other basic lipopeptides. Being water-soluble, these novel analogues are easy to apply and they are suitable for field studies as adjuvants when sonication can not usually be provided.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082887     DOI: 10.1016/S0171-2985(11)80283-4

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  2 in total

1.  Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Dorota Klaczkowska; Malin Hultqvist; Kristin Hagenow; Rikard Holmdahl; Kutty Selva Nandakumar
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

2.  Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2011-05-04       Impact factor: 4.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.